Inosine 5'-Monophosphate to Raise of Serum Uric Acid Level in Patients With Multiple System Atrophy: a Multi-center, Randomized Controlled, Double Blind, Parallel Assigned Clinical Trial

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2018
A purpose of the present study is to investigate the capability of serum uric acid elevation, safety, and tolerability of inosine 5\'-monophosphate in patients with multiple system atrophy with multicenter, randomized, placebo controlled, parallel assigned design. This may provide the cornerstone for future extended trial in multiple system atrophy, a debilitating disease to date.
Epistemonikos ID: edc0b33c618c471456ceb5879e1f3601ef67beb4
First added on: Mar 30, 2022